Xenon Pharmaceuticals (XENE) Tops Q4 EPS by 12c
Tweet
Share
E-mailGet Alerts XENE Hot Sheet
Join SI Premium – FREE
Xenon Pharmaceuticals (NASDAQ: XENE) reported Q4 EPS of ($0.64), $0.12 better than the analyst estimate of ($0.76).
For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Xenon Reports Q2 2026 Financial Results and Provides Business Update
- Xenon Pharmaceuticals (XENE) PT Lowered to $81 at RBC Capital
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
